InnoCare Pharma concludes subject enrolment Phase II psoriasis trial
The trial aims to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ICP-488 in adult patients.
Stay updated with breaking news from Care Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The trial aims to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ICP-488 in adult patients.
InnoCare Pharma Limited (OTCMKTS:INCPF – Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,943,400 shares, a growth of 8.4% from the March 31st total of 2,714,400 shares. Based on an average trading volume of 0 shares, […]
InnoCare Pharma Limited (OTCMKTS:INCPF – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 2,943,400 shares, an increase of 8.4% from the March 31st total of 2,714,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio […]
BEIJING--(BUSINESS WIRE)--Dec 17, 2023--
BEIJING--(BUSINESS WIRE)--Dec 10, 2023--